Acceptance of HIV pre-exposure prophylaxis (PrEP) referral among a sample of PrEP-eligible emergency department patients

被引:5
|
作者
Faryar, Kiran A. [1 ,4 ]
Braun, Robert [1 ]
Ancona, Rachel M. [1 ]
Freiermuth, Caroline [1 ,3 ]
Lyons, Michael S. [1 ,2 ,3 ]
机构
[1] Univ Cincinnati, Dept Emergency Med, Coll Med, 231 Albert Sabin Way,POB 670769, Cincinnati, OH 45267 USA
[2] Univ Cincinnati, Dept Psychiat & Behav Neurosci, Addict Sci Div, Coll Med, 260 Stetson St,POB 670559, Cincinnati, OH 45267 USA
[3] Univ Cincinnati, Ctr Addict Res, Coll Med, 3230 Eden Ave, Cincinnati, OH 45267 USA
[4] Cleveland Med Ctr, Univ Hosp, 11100 Euclid Ave B519B, Cleveland Hts, OH 44106 USA
来源
关键词
HIV; Pre-exposure prophylaxis; Emergency department; PrEP acceptance; PrEP referral; UNITED-STATES;
D O I
10.1016/j.ajem.2022.07.055
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: Pre-exposure prophylaxis (PreP) reduces the rate of HIV transmission in high-risk groups. Emergency departments (EDs) frequently encounter patients at risk for HIV acquisition who are eligible for PrEP. ED HIV screening programs have prioritized testing and linkage to care for patients who test positive, but fail to refer HIV-negative patients to PrEP clinicians. Our objective was to estimate referral acceptance to a PrEP clinician among a sample of at-risk ED patients.Methods: This single-center cross-sectional study electronically queried a prospectively acquired dataset of sur-vey responses from a sample of patients presenting to an urban academic ED from March 2019 to February 2020. Patients completed a risk assessment as part of the HIV screening program. PrEP eligibility was based off survey responses in accordance with 2017 CDC PrEP eligibility criteria. Identified PrEP-eligible patients completed a PrEP questionnaire. The primary outcome was the proportion of PrEP-eligible patients who accepted referral to a PrEP clinician during their ED encounter. We secondarily report patient participant characteristics including the proportion of PrEP-eligible patients who were aware of and were knowledgeable about PrEP as a method to prevent transmission of HIV.Results: In total, 360 patients completed a PrEP questionnaire, of which 287 (80%) were not currently taking PrEP and eligible for PrEP referral. 57% were males, with 41% Black/African American. Of the 287 eligible for PrEP, 61 (21.3%, 95% CI: 16.8-26.5) indicated awareness of PrEP, of which, 49 (80.3%, 95% CI: 67.8-89.0) demonstrated accurate knowledge of PrEP. PrEP referral was offered to 238 (82.9%, 95% CI: 78.0-87.0) patients, of which, 76 (31.9%, 95% CI: 26.1-38.3) accepted.Conclusions: Approximately one third of PrEP-eligible ED patients accepted PrEP referral during their ED encoun-ter, demonstrating an opportunity for increased PrEP education and intentional referral for eligible patients. Var-iability in PrEP acceptability by demographic and risk subgroup may be an important consideration in efforts to expand PrEP utilization.(c) 2022 Elsevier Inc. All rights reserved.
引用
收藏
页码:152 / 155
页数:4
相关论文
共 50 条
  • [31] Validation of HIV Pre-Exposure Prophylaxis (PrEP) Medication Scales with Youth on PrEP: PrEP Confidence Scale and PrEP Difficulties Scale
    Budhwani, Henna
    Yigit, Ibrahim
    Maragh-Bass, Allysha C.
    Rainer, Crissi B.
    Claude, Kristina
    Muessig, Kathryn E.
    Hightow-Weidman, Lisa B.
    AIDS PATIENT CARE AND STDS, 2022, 36 (11) : 443 - 450
  • [32] HIV pre-exposure prophylaxis (PrEP): a review of current knowledge of oral systemic HIV PrEP in humans
    Christoph D. Spinner
    Christoph Boesecke
    Alexander Zink
    Heiko Jessen
    Hans-Jürgen Stellbrink
    Jürgen Kurt Rockstroh
    Stefan Esser
    Infection, 2016, 44 : 151 - 158
  • [33] HIV pre-exposure prophylaxis (PrEP): a review of current knowledge of oral systemic HIV PrEP in humans
    Spinner, Christoph D.
    Boesecke, Christoph
    Zink, Alexander
    Jessen, Heiko
    Stellbrink, Hans-Juergen
    Rockstroh, Juergen Kurt
    Esser, Stefan
    INFECTION, 2016, 44 (02) : 151 - 158
  • [34] Community pharmacists' acceptance of prescribing for pre-exposure prophylaxis (PrEP) for human immunodeficiency virus (HIV)
    Booker, Connor
    Murphy, Andrea L.
    Isenor, Jennifer E. E.
    Ramsey, Tasha D. D.
    Smith, Alesha J. J.
    Bishop, Andrea
    Kelly, Deborah V. V.
    Woodill, Lisa
    Richard, Greg
    Wilby, Kyle John
    CANADIAN PHARMACISTS JOURNAL, 2023, 156 (03) : 137 - 149
  • [35] Changes in the user profiles of HIV pre-exposure prophylaxis (PrEP) before and after PrEP reimbursement
    Ahaus, Patrick
    Schmidt, Axel J.
    Skaletz-Rorowski, Adriane
    Uhrmacher, Mona
    Serova, Katja
    Kayser, Arne
    Wach, Janet
    Nambiar, Sandeep
    Brockmeyer, Norbert H.
    Potthoff, Anja
    JOURNAL OF INFECTION AND PUBLIC HEALTH, 2022, 15 (09) : 955 - 960
  • [36] RETROSPECTIVE REVIEW OF HIGH-RISK ADOLESCENTS ELIGIBLE FOR PRE-EXPOSURE PROPHYLAXIS (PREP) THERAPY FOR HIV
    Costello, Cliff
    Mobley, Taylor
    Arnold, Sandra
    Bowden, Michelle
    JOURNAL OF ADOLESCENT HEALTH, 2020, 66 (02) : S123 - S124
  • [37] HIV Risk and Pre-Exposure Prophylaxis Eligibility Among Emergency Department Patients
    Haukoos, Jason S.
    White, Douglas A. E.
    Rowan, Sarah E.
    Lyle, Carolynn
    Gravitz, Stephanie
    Basham, Kellie
    Godoy, Ashley
    Kamis, Kevin
    Hopkins, Emily
    Anderson, Erik
    AIDS PATIENT CARE AND STDS, 2021, 35 (06) : 211 - 219
  • [38] Attitude towards antiretroviral pre-exposure prophylaxis (PrEP) prescription among HIV specialists
    Vincenzo Puro
    Antonio Palummieri
    Gabriella De Carli
    Pierluca Piselli
    Giuseppe Ippolito
    BMC Infectious Diseases, 13
  • [39] Willingness to Use Pre-Exposure Prophylaxis (PrEP) for HIV Prevention and PrEP Implementation Preferences Among Transgender Women in Malaysia
    Galka, Jonathan M.
    Wang, Melinda
    Azwa, Iskandar
    Gibson, Britton
    Lim, Sin How
    Shrestha, Roman
    Wickersham, Jeffrey A.
    TRANSGENDER HEALTH, 2020, 5 (04) : 258 - 266
  • [40] Attitude towards antiretroviral pre-exposure prophylaxis (PrEP) prescription among HIV specialists
    Puro, Vincenzo
    Palummieri, Antonio
    De Carli, Gabriella
    Piselli, Pierluca
    Ippolito, Giuseppe
    BMC INFECTIOUS DISEASES, 2013, 13